8 April 2020
Cytel has launched an open-access global COVID-19 Clinical Trial Tracker. This visual tool, funded in part by the Bill & Melinda Gates Foundation, is intended to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak.
The live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic. Since the outbreak started, around 500 trials have commenced – a number that is growing daily. Collating information on the trials should enable decision-makers to compare treatments more easily as they determine which to investigate further.
Cytel is committed to keeping the dashboard up to date with the latest information. In addition, the company is currently working with a number of clients on COVID-19 clinical trials.